Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer DOI Creative Commons

Qiying Song,

Shihe Liu, Di Wu

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Фев. 4, 2025

Background Gastric cancer (GC) is a malignant tumor with poor prognosis. The diverse patterns of programmed cell death (PCD) are significantly associated the pathogenesis and progression GC, it has potential to serve as prognostic drug sensitivity indicators for GC. Method sequencing data clinical characteristics GC patients were downloaded from Cancer Genome Atlas GEO databases. LASSO cox regression method was used screen feature genes develop PCD score (PCDS). Immune infiltration, immune checkpoint expression, Tumor Dysfunction Exclusion (TIDE) algorithm analysis explore immunotherapy response. By integrating PCDS characteristics, we constructed validated nomogram that demonstrated robust predictive performance. Results We screened nine PCD-related (SERPINE1, PLPPR4, CDO1, MID2, NOX4, DYNC1I1, PDK4, MYB, TUBB2A) create PCDS. found high experienced poorer prognoses, identified an independent factor. Furthermore, there significant difference in profile between low groups. Additionally, indicated may exhibit resistance standard adjuvant chemotherapy regimens; however, they benefit FDA-approved Dasatinib. Conclusion Overall, confirmed risk factor valuable predictor response patients, which provides new evidence application

Язык: Английский

Targeting ROS in cancer: rationale and strategies DOI
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham

и другие.

Nature Reviews Drug Discovery, Год журнала: 2024, Номер 23(8), С. 583 - 606

Опубликована: Июль 9, 2024

Язык: Английский

Процитировано

118

Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity DOI
Pascal Meier, Arnaud J. Legrand, Dieter Adam

и другие.

Nature reviews. Cancer, Год журнала: 2024, Номер 24(5), С. 299 - 315

Опубликована: Март 7, 2024

Язык: Английский

Процитировано

99

Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive Treatment DOI

Yao Xiong,

Yan Rao,

Jiawei Hu

и другие.

Advanced Materials, Год журнала: 2023, Номер unknown

Опубликована: Авг. 10, 2023

Rapid advancements in materials science and nanotechnology, intertwined with oncology, have positioned photothermal therapy (PTT) as a promising noninvasive treatment strategy for cancer. The breast's superficial anatomical location aesthetic significance render breast cancer particularly pertinent candidate the clinical application of PTT following melanoma. This review comprehensively explores research conducted on various types nanoparticles employed elaborates their specific roles mechanisms action. integration existing therapies is scrutinized, underscoring its potential synergistic outcomes. Additionally, underlying consequential modifications to tumor microenvironment after are elaborated from medical perspective. Future directions suggested, an emphasis development integrative platforms that combine multiple therapeutic approaches optimization nanoparticle synthesis enhanced efficacy. goal push boundaries toward comprehensive, clinically applicable

Язык: Английский

Процитировано

82

Cuproptosis: Harnessing Transition Metal for Cancer Therapy DOI
Wuyin Wang, Wentao Mo, Zishan Hang

и другие.

ACS Nano, Год журнала: 2023, Номер 17(20), С. 19581 - 19599

Опубликована: Окт. 11, 2023

Transition metal elements, such as copper, play diverse and pivotal roles in oncology. They act constituents of metalloenzymes involved cellular metabolism, function signaling molecules to regulate the proliferation metastasis tumors, are integral components metal-based anticancer drugs. Notably, recent research reveals that excessive copper can also modulate occurrence programmed cell death (PCD), known cuprotosis, cancer cells. This modulation occurs through disruption tumor metabolism induction proteotoxic stress. discovery uncovers a mode interaction between transition metals proteins, emphasizing intricate link homeostasis metabolism. Moreover, they provide innovative therapeutic strategies for precise diagnosis treatment malignant tumors. At crossroads chemistry oncology, we undertake comprehensive review elucidating molecular mechanisms underpinning cuproptosis. Additionally, summarize current nanotherapeutic approaches target cuproptosis an overview available laboratory clinical methods monitoring this process. In context emerging concepts, challenges, opportunities, emphasize significant potential nanotechnology advancement field.

Язык: Английский

Процитировано

80

Cancer cell-intrinsic mechanisms driving acquired immune tolerance DOI Creative Commons
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada

и другие.

Immunity, Год журнала: 2023, Номер 56(10), С. 2270 - 2295

Опубликована: Окт. 1, 2023

Immune evasion is a hallmark of cancer, enabling tumors to survive contact with the host immune system and evade cycle recognition destruction. Here, we review current understanding cancer cell-intrinsic factors driving evasion. We focus on T cells as key effectors anti-cancer immunity argue that destruction by gaining control over pathways usually serve maintain physiological tolerance self. Using this framework, place recent mechanistic advances in into broad categories cell localization, antigen recognition, acquisition optimal effector function. discuss redundancy involved identify knowledge gaps must be overcome better target evasion, including need for better, routinely available tools incorporate growing mechanisms stratify patients therapy trials.

Язык: Английский

Процитировано

50

Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis DOI

Tianqi Ming,

Jiarong Lei,

Yu‐Hui Peng

и другие.

Phytotherapy Research, Год журнала: 2024, Номер 38(8), С. 3954 - 3972

Опубликована: Июнь 4, 2024

Driven by iron-dependent lipid peroxidation, ferroptosis is regulated p53 and solute carrier family 7 member 11 (SLC7A11)/glutathione/glutathione peroxidase 4 (GPX4) axis in colorectal cancer (CRC). This study aimed to investigate the influence of curcumin (CUR) on CRC. The efficacies CUR malignant phenotype CRC cells were determined 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, wound healing, clonogenic assays. effects evaluated transmission electron microscopy, lactate dehydrogenase release assay, Fe

Язык: Английский

Процитировано

27

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics DOI Creative Commons

Ying Feng,

Zhibo Yang,

Jianpeng Wang

и другие.

Cell Communication and Signaling, Год журнала: 2024, Номер 22(1)

Опубликована: Май 1, 2024

Copper plays vital roles in numerous cellular processes and its imbalance can lead to oxidative stress dysfunction. Recent research has unveiled a unique form of copper-induced cell death, termed cuproptosis, which differs from known death mechanisms. This process involves the interaction copper with lipoylated tricarboxylic acid cycle enzymes, causing protein aggregation death. Recently, growing number studies have explored link between cuproptosis cancer development. review comprehensively examines systemic metabolism copper, including tumor-related signaling pathways influenced by copper. It delves into discovery mechanisms connection various cancers. Additionally, suggests potential treatments using ionophores that induce combination small molecule drugs, for precision therapy specific types.

Язык: Английский

Процитировано

19

Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy DOI Open Access
Ziyin Chen, Ziqi Yue,

Kaiqi Yang

и другие.

Advanced Healthcare Materials, Год журнала: 2023, Номер 12(26)

Опубликована: Авг. 4, 2023

Abstract The application of nanomaterials in healthcare has emerged as a promising strategy due to their unique structural diversity, surface properties, and compositional diversity. In particular, have found significant role improving drug delivery inhibiting the growth metastasis tumor cells. Moreover, recent studies highlighted potential modulating microenvironment (TME) enhancing activity immune cells improve therapy efficacy. Various types are currently utilized carriers, immunosuppressants, activators, immunoassay reagents, more for immunotherapy. Necessarily, used immunotherapy can be grouped into two categories: organic inorganic nanomaterials. Though both shown ability achieve purpose immunotherapy, composition properties result differences mechanisms modes action. Organic further divided polymers, cell membranes, nanoemulsion‐modified, hydrogel forms. At same time, broadly classified nonmetallic metallic current work aims explore action these different prospects promoting

Язык: Английский

Процитировано

31

Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics DOI Creative Commons
Liqiang Zhou, Yangmengfan Chen, Dong Xie

и другие.

BMEMat, Год журнала: 2024, Номер unknown

Опубликована: Март 4, 2024

Abstract Nanomedicine‐assisted sonodynamic therapy (SDT) has emerged as one of the most promising cancer therapies due to its unique advantages high penetration, non‐radiation, and excellent oxidative stress effect, but always suffered from self‐protection mechanism apoptosis resistance characteristics evolutionarily mutated cells. Regulated cell death (RCD) received increasing attention in precision treatments because significant role synergistically sensitizing reversing immunosuppressive microenvironment during SDT nanomedicine‐triggered immunogenic death. Herein, paradigmatic research RCD‐augmented tumor immunotherapeutics are typically introduced, such autophagy blockade, ferroptosis targeting, pyroptosis induction, necroptosis initiation, cuproptosis actuation, PANoptosis trigger, coordinated anti‐tumor mechanisms discussed detail. Multiple analysis focusing on currently unsolved problems future development prospects RCD‐based nano‐oncology medicine also prospected further strengthen expand scope therapeutic applications.

Язык: Английский

Процитировано

14

Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity DOI
Yihong Wei, Wancheng Liu, Ruiqing Wang

и другие.

Free Radical Biology and Medicine, Год журнала: 2024, Номер 213, С. 36 - 51

Опубликована: Янв. 11, 2024

Язык: Английский

Процитировано

12